Verrica Pharmaceuticals Inc (VRCA)

Jun 18, 2025

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Sees Significant Decline in Short Interest - Defense World

Jun 18, 2025

Jun 18, 2025

Verrica Pharmaceuticals Reports Third Quarter 2021 Financial Results - Barchart.com

Jun 18, 2025

Jun 16, 2025

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Given Average Recommendation of “Hold” by Brokerages - Defense World

Jun 16, 2025

Jun 13, 2025

Shareholders May Not Overlook Verrica Pharmaceuticals Insiders Selling US$1.1m In Stock - simplywall.st

Jun 13, 2025

Jun 12, 2025

Verrica Pharmaceuticals amends credit agreement By Investing.com - Investing.com South Africa

Jun 12, 2025

Jun 12, 2025

Verrica Pharmaceuticals Amends Credit Agreement with OrbiMed - TipRanks

Jun 12, 2025

Jun 12, 2025

Verrica Pharmaceuticals amends credit agreement - Investing.com

Jun 12, 2025

Jun 12, 2025

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA): Are Analysts Optimistic? - Yahoo Finance

Jun 12, 2025

Jun 10, 2025

Verrica Pharmaceuticals (NASDAQ:VRCA) Shares Up 0% – Here’s Why - Defense World

Jun 10, 2025

Jun 05, 2025

Verrica Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks

Jun 05, 2025

May 30, 2025

Verrica Pharmaceuticals to Present at Jefferies Global Healthcare Conference - MSN

May 30, 2025

May 28, 2025

Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York - GlobeNewswire

May 28, 2025

May 28, 2025

Verrica Pharmaceuticals CEO Reveals Dermatology Pipeline Updates at Jefferies Healthcare Conference - Stock Titan

May 28, 2025

May 25, 2025

Verrica Pharmaceuticals (NASDAQ:VRCA) Upgraded at Wall Street Zen - Defense World

May 25, 2025

May 25, 2025

Brokerages Set Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Target Price at $8.00 - Defense World

May 25, 2025

May 24, 2025

Verrica Pharmaceuticals Reports Record Q1 Revenue and Advancements in Pipeline - MSN

May 24, 2025

May 22, 2025

Verrica Pharmaceuticals Reports Strong First-Quarter Growth for YCANTH - MSN

May 22, 2025

May 21, 2025

Common Warts Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Verrica Pharma, Kino Pharma, Iwaki Pharma, Aclaris Therapeutics, KinoPharma Inc - The Globe and Mail

May 21, 2025

May 20, 2025

Verrica Pharmaceuticals’ SWOT analysis: stock faces cash crunch amid YCANTH growth - Investing.com Canada

May 20, 2025

May 20, 2025

Verrica Pharmaceuticals Adds Dr. Gavin Corcoran to Board of Directors - MSN

May 20, 2025

May 20, 2025

Verrica reports high response rate in skin cancer study - MSN

May 20, 2025

May 19, 2025

Research Analysts Offer Predictions for VRCA Q2 Earnings - Defense World

May 19, 2025

May 16, 2025

Needham & Company LLC Reiterates “Hold” Rating for Verrica Pharmaceuticals (NASDAQ:VRCA) - Defense World

May 16, 2025

May 15, 2025

Verrica signals sustainable growth trajectory as YCANTH revenues surpass $3M and Phase 3 milestone looms - MSN

May 15, 2025

May 15, 2025

RBC Capital Reaffirms Their Hold Rating on Verrica Pharmaceuticals (VRCA) - The Globe and Mail

May 15, 2025

May 14, 2025

Verrica Pharmaceuticals to Host Q1 2025 Earnings Call and Corporate Update - MSN

May 14, 2025

May 14, 2025

Verrica Pharmaceuticals (VRCA) Sees Q1 Revenue Growth Driven by YCANTH - GuruFocus

May 14, 2025

May 14, 2025

Verrica Pharmaceuticals (VRCA) Receives Hold Rating from Needham - GuruFocus

May 14, 2025

May 14, 2025

Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 14, 2025

May 14, 2025

Verrica Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025

May 14, 2025

Verrica Pharmaceuticals Inc (VRCA) Q1 2025 Earnings Call Highlig - GuruFocus

May 14, 2025

May 14, 2025

Verrica Pharmaceuticals Inc (VRCA) Q1 2025 Earnings Call Highlights: Strong YCANTH Demand and ... - Yahoo Finance

May 14, 2025

May 14, 2025

Verrica Pharmaceuticals Reports Strong Q1 2025 Growth - TipRanks

May 14, 2025

May 13, 2025

Earnings call transcript: Verrica Pharmaceuticals Q1 2025 results show revenue growth By Investing.com - Investing.com South Africa

May 13, 2025

May 13, 2025

Verrica Pharmaceuticals Q1 2025 Earnings: EPS Misses, Revenue Su - GuruFocus

May 13, 2025

May 13, 2025

Earnings call transcript: Verrica Pharmaceuticals Q1 2025 results show revenue growth - Investing.com India

May 13, 2025

May 13, 2025

Verrica Pharmaceuticals (VRCA) Reports Strong Q1 Revenue and Adv - GuruFocus

May 13, 2025

May 13, 2025

Verrica Pharmaceuticals Reports Quarterly 2025 Financial Results - The Manila Times

May 13, 2025

May 13, 2025

West Pharmaceutical Services to Present at Upcoming Healthcare and Growth Stock Conferences - MyChesCo

May 13, 2025

May 12, 2025

Earnings To Watch: Verrica Pharmaceuticals Inc (VRCA) Reports Q1 2025 Result - GuruFocus

May 12, 2025

May 11, 2025

Verrica Pharmaceuticals (VRCA) Expected to Announce Earnings on Tuesday - Defense World

May 11, 2025

May 11, 2025

Head-To-Head Comparison: KalVista Pharmaceuticals (NASDAQ:KALV) and Verrica Pharmaceuticals (NASDAQ:VRCA) - Defense World

May 11, 2025

May 08, 2025

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q4 2024 Earnings Call Transcript - MSN

May 08, 2025

May 07, 2025

Verrica Pharmaceuticals at The Citizens JMP Life Sciences Conference: Strategic Developments in Dermatology - Investing.com Canada

May 07, 2025